drugset / Trial / NCT03747926
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective of this trial is to investigate the safety and tolerability of BI 705564 in healthy male subjects following oral administration of single rising doses. A secondary objective is the exploration of the PK including dose proportionality of BI 705564 after single dosing.
Timeline
- Start
- 2019-04-05
- Primary completion
- 2019-08-12
- Completion
- 2019-09-02
Outcome
Outcome not reported
Stopped: “Substance discontinued.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 705564 | Unknown | — | Oral |
Indications
No indication recorded.